InsiderTrades

Form 4 for AXSM Axsome Therapeutics, Inc.

Accepted 2024-03-15 00:00:00 ET · period of report 2024-03-14 · accession 0000950170-24-032432 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMT 2024-03-15 2024-03-14+ AXSM JEFFS ROGER Dir S - Sale+OE $69.84 -32.3K 120.8K -21% -$2.26M
DMT 2024-03-15 2024-03-14+ AXSM JEFFS ROGER Dir M - OptEx $24.44 +32.3K 137.7K +31% +$790.0K
DMT 2024-03-15 2024-03-14+ AXSM JEFFS ROGER Dir M - OptEx $0.00 -32.3K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-03-14 S D 13,000 $69.70 120,756 D — —
2 Common Common Stock 2024-03-15 S D 2,347 $71.61 120,756 D — —
3 Common Common Stock 2024-03-14 S D 16,976 $69.70 120,756 D — —
4 Common Common Stock 2024-03-15 M A 2,347 $29.91 123,103 D — —
5 Common Common Stock 2024-03-14 M A 13,000 $22.03 133,756 D — —
6 Common Common Stock 2024-03-14 M A 16,976 $25.53 137,732 D — —
7 Derivative Stock Option (Right to Buy) 2024-03-14 M D 13,000 $0.00 0 D $22.03 · 2020-06-07 to 2029-06-07 13,000 Common Stock
8 Derivative Stock Option (Right to Buy) 2024-03-15 M D 2,347 $0.00 0 D $29.91 · 2022-03-04 to 2032-03-04 2,347 Common Stock
9 Derivative Stock Option (Right to Buy) 2024-03-14 M D 16,976 $0.00 0 D $25.53 · 2023-06-03 to 2032-06-03 16,976 Common Stock